These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


169 related items for PubMed ID: 10584994

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Response of vasoactive substances to intermittent ultrafiltration in normotensive hemodialysis patients.
    Heintz B, Königs F, Dakshinamurty KV, Kierdorf H, Gladziwa U, Kirsten R, Nelson K, Wieland D, Riehl J, Mann H.
    Nephron; 1993; 65(2):266-72. PubMed ID: 8247191
    [Abstract] [Full Text] [Related]

  • 3. Response of vasoactive substances to reduction of blood volume during hemodialysis in hypotensive patients.
    Heintz B, Reiners K, Gladziwa U, Kirsten R, Nelson K, Wieland D, Riehl J, Mann H, Sieberth HG.
    Clin Nephrol; 1993 Apr; 39(4):198-204. PubMed ID: 8491049
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Evaluation of markers to estimate volume status in hemodialysis patients: atrial natriuretic peptide, inferior vena cava diameter, blood volume changes and filtration coefficients of microvasculature.
    Yashiro M, Kamata T, Yamadori N, Tomita M, Muso E.
    Ther Apher Dial; 2007 Apr; 11(2):131-7. PubMed ID: 17381534
    [Abstract] [Full Text] [Related]

  • 6. [Response of vasoactive substance to blood pressure changes during hemodialysis in uremic patients].
    Witkowicz J, Kokot F, Irzyniec T, Chudek J, Ficek R.
    Pol Arch Med Wewn; 1999 Sep; 102(3):763-71. PubMed ID: 10949883
    [Abstract] [Full Text] [Related]

  • 7. Fluid balance in patients with chronic renal failure assessed with N-terminal proatrial natriuretic peptide, atrial natriuretic peptide and ultrasonography.
    Metry G, Hall C, Wikström B, Källskog V, Hansell P, Danielson B.
    Acta Physiol Scand; 2001 Feb; 171(2):117-22. PubMed ID: 11350271
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Neurohumoral responses to a single haemodialysis in chronic renal patients.
    Uusimaa P, Huttunen K, Ruskoaho H, Linnaluoto M, Ikäheimo M.
    Acta Physiol Scand; 1999 Jan; 165(1):25-31. PubMed ID: 10072093
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Influence of erythropoietin treatment on plasma renin activity, aldosterone, vasopressin and atrial natriuretic peptide in haemodialyzed patients.
    Kokot F, Wiecek A, Grzeszczak W, Klin M.
    Miner Electrolyte Metab; 1990 Jan; 16(1):25-9. PubMed ID: 2139159
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Plasma atrial natriuretic peptide during brief upright and supine exercise in humans.
    Perrault H, Cantin M, Thibault G, Brisson GR, Brisson G, Beland M.
    J Appl Physiol (1985); 1989 May; 66(5):2159-67. PubMed ID: 2526114
    [Abstract] [Full Text] [Related]

  • 19. Alterations of vasoconstrictor and sodium-regulating hormone systems in vascularly decompensated liver cirrhosis.
    Tulassay T, Tulassay Z, Büki B, Szathmári M, Rascher W.
    Acta Med Hung; 1988 May; 45(1):73-81. PubMed ID: 2970621
    [Abstract] [Full Text] [Related]

  • 20. Plasma concentrations of atrial natriuretic peptide, arginine vasopressin and hormones of the renin-angiotensin system in patients with end-stage renal disease.
    Elias AN, Vaziri ND, Pandian MR, Kaupke J.
    Int J Artif Organs; 1989 Mar; 12(3):153-8. PubMed ID: 2526100
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.